44 results about "Parenteral nutrient" patented technology

A composition and method for improved parenteral administration of nutrients is provided. The method comprises co-administration of nutrients, especially carbohydrates, and an insulinotropic peptide, or its derivatives, analogs, and fragments. The method and composition provide high carbohydrate nutrition while avoiding hyper- and hypoglycemia and their attendant deleterious effects.

A multiple chamber container for separately storing components of a parenteral nutritional formulation is provided. The multiple chamber container may include frangible barriers, preferably peelable seals separating the chambers from each other. The container preferably facilitates the selective activation of the peelable seals to permit the admixing of less than all the separately stored components. The container may include a chamber positioned at each of the opposite lateral ends of the container and at least one additional chamber between the lateral chambers. The at least one additional chamber may have a longitudinal length substantially less than the longitudinal length of at least one of the lateral chambers. This configuration allows for selective opening of the seals since when rolling the container from the top avoids pressurizing the at least one additional chamber and inadvertent activation of a seal. The longitudinal length of the at least one additional chamber may be from about two-thirds to about three-fourths the longitudinal length of at least one of the lateral chambers. Alternatively, the container may include a hanger flap extending from a top end of the container towards the bottom end a substantially greater distance relative to the at least one additional chamber than the lateral chambers.

Bioavailable iron-containing parenteral nutrition compositions are provided that are physico-chemically stable. Iron is present in the form of soluble ferric pyrophosphate. Methods of preparation and use of the compositions are provide, as well as kits.

The invention provides a food capable of treating diarrhea, which is mainly composed of special carbohydrates and combined with other nutritional ingredients for regulating the intestines and stomach. Mix one or more of commercially available carbohydrates such as rice flour, flour, edible starch, and edible dextrin at a certain temperature or fry for a certain period of time to make a burnt-yellow powder containing caramelized sugar; Baking yam, hawthorn, dark plum, kudzu root, cinnamon, Atractylodes macrocephala, licorice, clove, nutmeg, Poria cocos, barley, Huoxiang, amomum, jujube, white lentils and other Chinese herbal medicines that can strengthen the spleen and stomach, or Stir-fry until slightly yellow, grind into powder; add a certain amount of whey protein, probiotics, prebiotics, glutamine, vitamin A, vitamin B, vitamin B2 and salt. The fried or baked food for treating diarrhea of ​​the invention can be absorbed by the intestinal tract, is suitable as food for patients with diarrhea, and is easily digested and absorbed by patients, so that patients with diarrhea can recover as soon as possible without side effects and has stable curative effect.

Dietary formulations in the form of an oil emulsion providing total enteral or parenteral nutrition, or in the form of food oil suitable for oral administration is provided. The formulations include about 2-60% by calories of a C20 or longer omega-3 fatty acid and about 0.05% to 1% by calories of arachidonic acid, where the formulation provides less than 1% of total calories from linoleic acid and alpha-linolenic acid, and where the fatty acids provide 5-60% of the total calories of said dietary formulation. Methods for treatment of diseases and disorders using the dietary formulations are also provided.

The invention discloses a medical infusion bag. The infusion bag is manufactured by using polypropylene and polyethylene and styrene-ethylene / butylene-styrene block copolymer. The infusion bag manufactured by adopting the technical scheme has the advantages that: the air-tightness and the steam resistance are excellent, the chemical stability is high, and the infusion bag is suitable to be used for manufacturing liquid medicinal products requiring high-temperature disinfection and sterilization; the transparence is high, and the detection of foreign materials when the infusion bag is produced and used is ensured; the softness is high, the falling resistance is high, the heat-sealing property is high, the high-temperature resistance is high, and the infusion bag can be sterilized at the temperature of 121 DEG C; because the infusion bag does not contain halogens, the infusion bag does not cause any environmental pollution when processed after use; and simultaneously, the barrier property is high, the chemical inertness and the biological inertness are high, the compatibility with medicaments is good, and the infusion bag can be used for packaging various kinds of common fluid, enteral nutrient fluid, parenteral nutrient fluid, dialyzate, flushing fluid, treating type large-capacity injection and the like.

The invention relates to walnut oil intralipid and process for preparation, belonging to the technical field of food and drug. The formulation comprises pure walnut oil, refining lecithin, pure glycerin, caustic soda and pyrogen-free pure water. The basic preparing procedures are as follows: pure walnut oil, refining lecithin, glycerin and water are vigorously stirred into primary milk and the pH value of the primary milk is adjusted to 7.5-8.5 through little caustic soda solution, and then high-pressured and homogenized, filtered by a filter, bottled, sealed and sterilized. The walnut oil intralipid is an artificial chyle product which is prepared by simulating natural chyle granules existing in blood and can be intravenously injected as 'parenteral nutrient solution' to rescue lives of some severe patients, (such as severely burned patients, traffic accident injured patients, patients with great operations, patients with advanced tumor and cachexia, etc.) and furthermore can be used for complementarily curing some dystrophic diseases and also can be orally taken as nutrition supplementary and auxiliary treatment. The invention can increase essential energy for body metabolism, provide biological film for body and essential 'polyunsaturated fatty acid' for biologically active substance metabolism, and prevent and correct deficiency of essential fatty acid for body. The invention has a plurality of therapeutic functions of blood sugar reduction, anti-oxidative damage, anti-anaphylaxis, anti-cell senescence, and anti-cardiovascular hardness and the like, and provides a new direct and convenient way through which edible and medical walnut effective component can enter human body.

The present invention relates to a difructose anhydride (DFA)-containing composition and use thereof. DFA is a cyclic disaccharide in which the reducing termini of two fructose molecules bind each other to hydroxyl groups at the other nonreducing termini. According to the present invention, it has been revealed that DFA is effective in accelerating the absorption of magnesium, zinc or copper, accelerating bone formation, accelerating diuretic action, and improving bowel movement and is useful in inhibiting dental caries. A composition of the present invention can be used as a composition for a medicinal product and a food or drink product (including feed for animal use). Examples of a medicinal product and a food or drink product for human or animal use include formulated powder milk, parenteral nutrients, health food and drink products, and additives for feed and are not particularly limited as long as they are ultimately in an orally administrable form.

Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.

A composition and method for improved parenteral administration of nutrients is provided, comprising administration of an insulinotropic peptide, or its derivatives, analogs, and fragments. GLP-1 is a preferred insulinotropic hormone. Patients who are especially suited for treatment include patients with activated counterregulatory hormones, such as would occur after trauma, accidents, and surgery.

The present invention relates to a method of treating a life threatening condition in a critically ill human patient with a non-infectuous disorder, wherein the critically ill patient is a patient receiving enteral or parenteral nutrition, the method comprising the step of administering to said patient an autophagy inducing agent.

A neonatal nutrition assessment system is disclosed that includes a remote terminal connected with a server as well as several software modules. A patient diagnosis module operable to allow a physician to record at least one diagnosis relating to a patient with the remote terminal. A parenteral nutrition software module operable to allow the physician to record a parenteral nutrition prescription for a predetermined time period including at least one parenteral nutrition solution to be given the patient. An enteral nutrition software module operable to allow the physician to record an enteral nutrition prescription for the predetermined time period including at least one enteral nutrition solution to be given the patient. An outputs software module operable to allow a user to record a plurality of bodily output values for the patient over the predetermined time period. A medication software module operable to allow the physician to record at least one medication prescription for the patient. A laboratory software module operable to record a plurality of lab results for the patient over the predetermined time period.

The invention relates to an improved intravenously dripped multi-vitamin injection. The injection can be mixed with high-calorie parenteral nutrients to be dissolved and adjusted to have isotonicity and isostension and then can be administrated through peripheral intravenous drip, wherein the intravenously dripping time is 6 to 12 hours; and dripping is performed at constant speed and for one time per day.

The invention discloses a Microsoft Excel-based child parenteral nutrition calculation table manufacturing method. The method includes the steps of utilizing a data processing and analysis function ofa Microsoft Excel table, and combined with child parenteral nutrition knowledge, manufacturing a child parenteral nutrition calculation table; setting quantitative parameters in the child parenteralnutrition calculation table and an operational formula; and filling in the child parenteral nutrition calculation table, and using a calculation function of Microsoft Excel to output an analysis result. The Microsoft Excel-based child parenteral nutrition calculation table manufacturing method provided by the invention not only can calculate the doctor's advice value of each component in a parenteral nutrient solution, but also can calculate relevant parameters of the parenteral nutrient solution, is accurate, rapid and convenient, and effectively solves the problems of being complicated in calculation, being time-consuming and being easy to generate errors which exist in an existing parenteral nutrient solution preparation process.

A parenteral nutritional diagnostic system, apparatus, and method are disclosed. In an example embodiment, a parenteral nutritional diagnostic apparatus determines muscle quantity and muscle quality of a patient's psoas muscle to determine a nutritional status of the patient. An image interface is configured to receive a medical image including radiodensity data related to imaged tissue of the patient. The apparatus also includes a processor configured to use the medical image to determine a tissue surface area for each different value of radiodensity and determine a distribution of the tissuesurface area for each radiodensity value. The processor is configured to determine muscle quality by locating a soft tissue peak within the distribution that corresponds to a local peak in at a region related to at least one of muscle tissue, organ tissue, and intramuscular adipose tissue. The processor determines the nutritional status of the patient based on soft tissue peak.

The invention belongs to the technical field of nutrient solution preparation, and particularly relates to a parenteral nutrient solution preparation device and a preparation method thereof. The device comprises an outer cylinder and an injection module, the injection module is clamped to the top of the outer cylinder, and a second protective cover is fixedly connected to the outer side of the outer cylinder; in the present invention, a first fan-shaped cavity, a second fan-shaped cavity and a third fan-shaped cavity are formed in the top of a mixing module; different kinds of liquid are respectively injected into the three fan-shaped cavities through the injection pipes; then, the mixed liquid is introduced into the mixing module to be stirred; the relative positions of a first-stage mixing cylinder, a second-stage mixing cylinder, a third-stage mixing cylinder and a fourth-stage mixing cylinder are adjusted through the output end of an electric push rod, the mixing uniformity degreeof nutrient solutions in the mixing module can be improved, redundant air in the mixing module can be exhausted according to the preparation amount of the nutrient solutions, the probability that impurities in the air pollute the nutrient solutions is reduced, and the preparation quality of the nutrient solutions is improved.

The invention discloses a total parenteral nutrient solution preparation device, and relates to the technical field of parenteral nutrient solution preparation. The device comprises a quantifying mechanism, a preparing mechanism, a stirring mechanism, a fixing mechanism and a shaking-up mechanism. The bolt is fixedly arranged on the inner surface of the clamping groove and penetrates through the inserting groove, and the outer surface of the threaded shaft is in threaded connection with the end cover, wherein the threaded shaft is rotatably arranged above the piston, the driving wheel is arranged on the outer surface of the sleeve shaft, the elastic piece is arranged on the outer surface of the pressing plate, and the transmission block is arranged at one end of the transmission rod. By arranging the quantifying mechanism, the preparing mechanism, the stirring mechanism, the fixing mechanism and the shaking-up mechanism, medicine can be conveniently and quantitatively injected, the medicine can be conveniently injected, stirring and uniform mixing are convenient, a nutrition bag can be conveniently fixed, a nutrient solution can be automatically shaken up, and the labor intensity of workers is reduced. Therefore, preparation operation of the nutrient solution is greatly facilitated, the preparation efficiency can be improved to a certain extent, and the device is suitable for large-scale preparation.

Electrolyte solutions are provided which are useful in electrolyte and fluid therapy, parenteral nutrition and dialysis. The Na:Cl ratio is normalized, plasma and cellular pH are normalized and cellular cofactor ratios are normalized in a manner which decreases toxicity over prior art solutions.

Methods are provided for treatment or prophylaxis of liver or kidney dysfunction in individuals experiencing one or more of intestinal failure, short bowel syndrome or parenteral nutrition by the administration of GLP-2 or GLP-2 analogs.

Problem to be SolvedThe present invention provides a technique replacing radiation exposure in decreasing or eliminating hematopoietic stem cells in an animal (particularly human) body.Solution A parenteral nutrition formula or an enteral nutrition formula substantially free of valine.

Described herein are compositions for parenteral administration that include an aqueous phase and 5 to 30%, by weight, of an oil phase, based on the total weight of the composition. The oil phase comprises the omega-3 fatty acid ethylesters eicosapentaenoic acid ethylester, docosahexaenoic acid ethylester, and mixtures thereof. The composition further comprises at least one anionic surfactant and at least one amphoteric surfactant, and less than 0.05% by weight of oleic acid, based on the total weight of the composition. Also described is a method for preparing such a composition as well as such compositions for use as a medicament, in particular for use in treating stroke, sepsis, Alzheimer's disease or cancer. Also featured are methods of treating these conditions by parenterally administering a composition to a patient in need thereof and methods of providing parenteral nutrition to such patients by administering to them a composition as described herein.

Provided is an enteral nutrient which, although containing a soy protein as a protein source, does not cause a rapid increase in viscosity and inhomogeneity due to aggregation or thermal denaturation by heating for sterilization or formulation step and is thus stable, and shows a good taste without giving any sense of bitterness and coarseness on the throat inherent to soybean. The enteral nutrient is an enteral nutrient of acidic type which comprises a protein, a fat, a carbohydrate, a vitamin, a mineral and a food fiber and has a pH of 3.0 to 4.5, wherein a soy protein containing 20 to 40% of a peptide fraction having a molecular weight of less than 6000 is formulated in an amount of 5 to 65% of the total protein.

The present invention discloses the use of one or more insulinotropic peptides and a nutritionally effective amount of at least one or more nutrients in the production of parenteral drugs for treating patients in need of parenteral nutrition, and also discloses a nutritionally effective amount of Parenteral nutrition compositions containing amounts of one or more nutrients and one or more insulinotropic peptides, and parenteral nutrition medicaments containing the compositions.

The invention relates to a high-amino-acid, low-lipid and low-carbohydrate parenteral nutrition solution for administration to obese intensive-care patients, and to a three-chamber pouch which comprises the amino acid component, the carbohydrate component and the lipid component of the parenteral nutrition solution separately in three different chambers.

The invention relates to the technical field of machines, and especially relates to a semiautomatic infusion preparation apparatus for a neonatal parenteral nutrient admixture. The apparatus comprisesa workbench, a rotating mechanism is mounted at one side of the top surface of the workbench, an infusion preparation box is mounted at one side, away from the rotating mechanism, of the top surfaceof the workbench, a suspension plate is mounted at the top of the rotating mechanism, the edge of the bottom surface of the suspension plate is provided with a plurality of uniformly equidistantly arranged hooks, and each hook is provided with a raw material accommodating device; and every raw material accommodating device includes a raw material accommodating box, one end part, away from the rawmaterial accommodating box, of a discharging tube, is connected with an infusion pump, and the outlet end of the infusion pump is connected with a first connector. The raw material accommodating device and the infusion preparation box are arranged, and are connected by a conduit to realize closed preparation and aseptic preparation; the infusion pumps can be used to accurately calculate the dosages of proportioned raw materials and control and display the dosages of the proportioned raw materials, so the dosages of the raw materials are accurate, and manpower and time are saved.